GSK Investigational Site
Mentor, Ohio 44060
1 studies enrolling now · 6 studies all time
What they study most
Anaemia, Diabetes Mellitus, Type 1, Gastroparesis, Irritable Bowel Syndrome, Neoplasms, Breast
Studies at this site
- A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) — Recruiting now
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
- A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis — Completed
- TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) — Stopped early
- Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
- Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed